Katherine Draper | White & Case LLP International Law Firm, Global Law Practice
Katherine Draper
Katherine Draper

Katherine Draper

Associate, New York

T +1 212 819 2520

E kdraper@whitecase.com

Overview

Katherine Draper is an associate in our Capital Markets group in New York, concentrating on debt and equity securities offerings, as well as securitization and structured finance transactions. Ms. Draper’s work also includes corporate governance, general corporate representations and ongoing disclosure and compliance requirements under U.S. securities laws. Ms. Draper has worked on business acquisitions, including public and private mergers.

Bars and Courts

  • New York State Bar

Education

  • JD, University of Texas School of Law
  • BA, University of Pennsylvania

Languages

  • English
  • French

Experience

Representation of Dynegy Inc., the third-largest independent power producer in the United States, in connection with its US$2.8 billion acquisition of power plants from Duke Energy Corporation.

Representation of Omnicare, Inc. in connection with its public offering of US$400 million principal amount of 4.75% Senior Notes due 2022 and US$300 million principal amount of 5.00% Senior Notes due 2024.

Representation of Electronic Funds Source LLC, a leader in innovative corporate payment solutions, in its sale to an affiliate of Warburg Pincus, LLC by its existing equity holders, an investor group consisting of an affiliate of CVC Capital Partners and Pilot Travel Centers LLC, First Data Transportation Services, Inc. and FJ Management Inc.

Representation of Jefferies LLC, as sole book-running manager, and Fifth Third Securities, Inc., Natixis Securities Americas LLC, PNC Capital Markets LLC, RBS Securities Inc., SMBC Nikko Securities America, Inc. and SunTrust Robinson Humphrey, Inc., as co-managers, in connection with the issuance of US$750 million in aggregate principal amount of 6% senior notes due 2021 by Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders.

Publications

  • Why Wars Without a Name May Need One: Policy-Based Application of International Humanitarian Law in the Algerian War, 48 Texas Int'l L. J. 575, 2013